EP3852773A4 - Aus verstorbenen spendern gewonnene zelluläre zusammensetzungen zur förderung der transplantationstoleranz und herstellung und verwendungen davon - Google Patents

Aus verstorbenen spendern gewonnene zelluläre zusammensetzungen zur förderung der transplantationstoleranz und herstellung und verwendungen davon Download PDF

Info

Publication number
EP3852773A4
EP3852773A4 EP19861568.4A EP19861568A EP3852773A4 EP 3852773 A4 EP3852773 A4 EP 3852773A4 EP 19861568 A EP19861568 A EP 19861568A EP 3852773 A4 EP3852773 A4 EP 3852773A4
Authority
EP
European Patent Office
Prior art keywords
manufacture
compositions derived
cellular compositions
graft tolerance
deceased donors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19861568.4A
Other languages
English (en)
French (fr)
Other versions
EP3852773A1 (de
Inventor
Michael Zdanowski
Colby SUIRE
D. Scott BATTY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medeor Therapeutics Inc
Original Assignee
Medeor Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medeor Therapeutics Inc filed Critical Medeor Therapeutics Inc
Publication of EP3852773A1 publication Critical patent/EP3852773A1/de
Publication of EP3852773A4 publication Critical patent/EP3852773A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0669—Bone marrow stromal cells; Whole bone marrow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP19861568.4A 2018-09-18 2019-09-18 Aus verstorbenen spendern gewonnene zelluläre zusammensetzungen zur förderung der transplantationstoleranz und herstellung und verwendungen davon Pending EP3852773A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862732830P 2018-09-18 2018-09-18
US201862732823P 2018-09-18 2018-09-18
US201862732827P 2018-09-18 2018-09-18
US201862732832P 2018-09-18 2018-09-18
PCT/US2019/051711 WO2020061180A1 (en) 2018-09-18 2019-09-18 Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereof

Publications (2)

Publication Number Publication Date
EP3852773A1 EP3852773A1 (de) 2021-07-28
EP3852773A4 true EP3852773A4 (de) 2022-06-29

Family

ID=69887779

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19861568.4A Pending EP3852773A4 (de) 2018-09-18 2019-09-18 Aus verstorbenen spendern gewonnene zelluläre zusammensetzungen zur förderung der transplantationstoleranz und herstellung und verwendungen davon

Country Status (6)

Country Link
EP (1) EP3852773A4 (de)
JP (1) JP2022502483A (de)
CN (1) CN113164517A (de)
AU (1) AU2019344937A1 (de)
CA (1) CA3112320A1 (de)
WO (1) WO2020061180A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11697799B2 (en) 2019-04-15 2023-07-11 Ossium Health, Inc. System and method for extraction and cryopreservation of bone marrow
WO2020247341A1 (en) * 2019-06-06 2020-12-10 Medeor Therapeutics, Inc. Methods of making cellular products by post-mortem mobilization and harvesting of hematopoietic cells
WO2022020210A1 (en) 2020-07-18 2022-01-27 Ossium Health, Inc. Permeation of whole vertebral bodies with a cryoprotectant using vacuum assisted diffusion
CA3195653A1 (en) 2020-10-14 2022-04-21 Ossium Health, Inc. Systems and methods for extraction and cryopreservation of bone marrow
WO2022133282A1 (en) 2020-12-18 2022-06-23 Ossium Health, Inc. Methods of cell therapies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015504047A (ja) * 2011-12-22 2015-02-05 イェダ リサーチ アンド デベロップメント カンパニー リミテッド 安定かつ長期の生着のための併用療法
GB2526228B (en) * 2013-02-26 2017-05-03 Univ Leland Stanford Junior Combined organ and hematopoietic cells for transplantation tolerance of grafts
US10881692B2 (en) * 2018-04-05 2021-01-05 Medeor Therapeutics, Inc. Compositions for establishing mixed chimerism and methods of manufacture thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LINK H ET AL: "Combined transplantation of allogeneic bone marrow and CD34+ blood cells", BLOOD, 1 October 1995 (1995-10-01), pages 2500 - 2508, XP055889577, Retrieved from the Internet <URL:https://ashpublications.org/blood/article-pdf/86/7/2500/622137/2500.pdf> [retrieved on 20220209], DOI: 10.1182/blood.V86.7.2500.bloodjournal8672500 *
See also references of WO2020061180A1 *
ZUBER JULIEN ET AL: "Mechanisms of Mixed Chimerism-Based Transplant Tolerance", TRENDS IN IMMUNOLOGY, vol. 38, no. 11, 1 November 2017 (2017-11-01), pages 829 - 843, XP085273403, ISSN: 1471-4906, DOI: 10.1016/J.IT.2017.07.008 *

Also Published As

Publication number Publication date
JP2022502483A (ja) 2022-01-11
EP3852773A1 (de) 2021-07-28
WO2020061180A1 (en) 2020-03-26
CN113164517A (zh) 2021-07-23
CA3112320A1 (en) 2020-03-26
AU2019344937A1 (en) 2021-04-08

Similar Documents

Publication Publication Date Title
EP3852773A4 (de) Aus verstorbenen spendern gewonnene zelluläre zusammensetzungen zur förderung der transplantationstoleranz und herstellung und verwendungen davon
EP3589291A4 (de) Zusammensetzungen und verfahren zur hemmung von zelllinienspezifischen proteinen
EP3823673A4 (de) Anti-cd112r-zusammensetzungen und verfahren
EP3697820A4 (de) Verfahren und zusammensetzungen im zusammenhang mit manipulierten regulatorischen t-zellen
EP3328455A4 (de) Herstellung eines azellulären knorpeltransplantats und verwendungen davon
EP3635095A4 (de) Leberorganoidzusammensetzungen und verfahren zur herstellung und verwendung davon
EP3790861A4 (de) Senolytische zusammensetzungen und deren verwendungen
EP3808357A4 (de) Zusammensetzung und verwendungen davon
EP3474665A4 (de) Aus menschengewebe gewonnene, lebensfähige lyophilisierte zusammensetzungen und verfahren zur herstellung davon
EP3630846A4 (de) Zusammensetzungen und verfahren zur zellulären immuntherapie
EP3615490A4 (de) Zusammensetzungen und verfahren für biologisch zementierte strukturen für meeresanwendungen
EP3899538A4 (de) Zusammensetzungen von streptavidin-oligo-konjugaten der pmhc-belegung
EP3844500A4 (de) Rp182-zusammensetzungen und verfahren
EP3589716A4 (de) Haftungsverbesserungszusammensetzungen
EP3843729A4 (de) Neuartige zusammensetzungen und verfahren
MX2017016842A (es) Proteinas de fijacion multiespecifica.
MX2019005933A (es) Polipeptidos biespecificos para gitr y ctla-4.
EP3836938A4 (de) Feste formen von substituiertem benzoxazol und zusammensetzungen davon
EP3491329A4 (de) Treibmittel und selbstschutzzusammensetzungen
EP3448947A4 (de) Ligninhaltige dichtungs- und/oder beschichtungszusammensetzungen aus erneuerbaren quellen
EP3307336A4 (de) Biomaterialzusammensetzungen, implantate und verfahren zur herstellung davon
EP3773634A4 (de) Zelluläre zusammensetzungen aus früheren organspendern und verfahren zu ihrer herstellung und ihrer verwendung
EP3890769A4 (de) Zusammensetzungen aus manipuliertem flagellin und verwendungen
EP3635059A4 (de) Konstruktionsmaterialien, zusammensetzungen und verfahren zur herstellung davon
EP3478325A4 (de) Eliminierung von proliferierenden zellen aus stammzellbasierten transplantaten

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210407

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220601

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 5/0789 20100101ALI20220525BHEP

Ipc: C12N 5/071 20100101ALI20220525BHEP

Ipc: A61P 37/06 20060101ALI20220525BHEP

Ipc: A61K 41/00 20200101ALI20220525BHEP

Ipc: A61K 35/28 20150101AFI20220525BHEP